ArticleDiscover oncology2025

Apigenin combined with cisplatin suppressed the progression of colorectal cancer by targeting the KRT23/Wnt/β-catenin signaling pathway.

Lei Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.